Veradermics, Inc (MANE): who owns it and who trades it
As of Nov 16, 2026, MANE insiders reported 16 open-market sales worth $141M and 23 purchases worth $34.8M in the last 12 months, with 9% of the sale value made under pre-set 10b5-1 plans. The largest seller was Averill Master Fund, Ltd. (Director), with $80.4M. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Veradermics
From the latest filingsOverall: more buying than selling. Funds, insiders and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns MANE
164 funds and institutions reported MANE shares worth $4.2B at the end of Q2 2026, about 92% of the company. The largest holder is Montanova Capital, LLC with 11.2%.
Funds and institutions (13F) 92%Everyone else 8%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Montanova Capital, LLC | 4.17M | 11.16% | $513M | No change |
| FMR LLC (Fidelity) | 3.20M | 8.58% | $394M | +79% |
| SR One Capital Management, LP | 2.40M | 6.43% | $295M | No change |
| Deep Track Capital, LP | 2.00M | 5.36% | $246M | +300% |
| Citadel Advisors LLC | 1.88M | 5.03% | $231M | +3% |
| Siren, L.L.C. | 1.66M | 4.43% | $204M | +10% |
| BlackRock, Inc. | 1.59M | 4.27% | $196M | +464% |
| Viking Global Investors LP | 1.56M | 4.18% | $192M | -8% |
| JPMorgan Chase & Co | 1.17M | 3.12% | $144M | New |
| Aberdeen Group plc | 1.10M | 2.94% | $135M | +4% |
| D. E. Shaw & Co., Inc. | 1.01M | 2.71% | $125M | +655% |
| Vanguard Capital Management LLC | 869,212 | 2.33% | $107M | +24% |
| Maverick Capital Ltd | 789,980 | 2.12% | $97.1M | New |
| Jennison Associates LLC | 748,678 | 2.01% | $92M | +428% |
| Infinitum Asset Management, LLC | 731,149 | 1.96% | $89.9M | No change |
| UBS Group AG | 670,727 | 1.80% | $82.5M | +93% |
| Marshall Wace, LLP | 585,560 | 1.57% | $72M | -11% |
| Adage Capital Partners Gp, L.l.c. | 549,706 | 1.47% | $67.6M | -50% |
| State Street Corp | 544,369 | 1.46% | $66.9M | +632% |
| Geode Capital Management, LLC | 508,067 | 1.36% | $62.5M | +185% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, MANE insiders reported $34.8M of open-market purchases and $141M of sales. 9% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Patrick G Enright | Director | Sale | 250,000 | $150.38 | $37.6M | Form 4 |
| Aug 19, 2026 | Averill Master Fund, Ltd. +3 | Director | Sale | 690,601 | $107.25 | $74.1M | Form 4 |
| Aug 19, 2026 | Averill Master Fund, Ltd. +3 | Director | Sale | 59,399 | $107.25 | $6.4M | Form 4 |
| Aug 17, 2026 | Timothy August Durso | Chief Technical Officer | Sale plan | 161 | $111.28 | $17.9K | Form 4 |
| Aug 17, 2026 | Timothy August Durso | Chief Technical Officer | Sale plan | 7,918 | $106.71 | $845K | Form 4 |
| Aug 17, 2026 | Timothy August Durso | Chief Technical Officer | Sale plan | 16,306 | $107.52 | $1.8M | Form 4 |
| Aug 17, 2026 | Timothy August Durso | Chief Technical Officer | Sale plan | 16,767 | $108.38 | $1.8M | Form 4 |
| Aug 17, 2026 | Timothy August Durso | Chief Technical Officer | Sale plan | 2,348 | $109.34 | $257K | Form 4 |
| Aug 17, 2026 | Reid Alexander Waldman | CEO | Sale plan | 11,527 | $106.72 | $1.2M | Form 4 |
| Aug 17, 2026 | Reid Alexander Waldman | CEO | Sale plan | 25,234 | $107.53 | $2.7M | Form 4 |
| Aug 17, 2026 | Reid Alexander Waldman | CEO | Sale plan | 27,490 | $108.45 | $3M | Form 4 |
| Aug 17, 2026 | Reid Alexander Waldman | CEO | Sale plan | 3,000 | $109.38 | $328K | Form 4 |
| Aug 17, 2026 | Reid Alexander Waldman | CEO | Sale plan | 249 | $111.28 | $27.7K | Form 4 |
| Aug 12, 2026 | John W Childs | Director | Sale | 15,000 | $106.14 | $1.6M | Form 4 |
| Aug 12, 2026 | John W Childs | Director | Sale | 5,000 | $108.24 | $541K | Form 4 |
| Aug 12, 2026 | John W Childs | Director | Sale | 80,000 | $107.23 | $8.6M | Form 4 |
| Feb 6, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 11,183 | $35.97 | $402K | Form 4 |
| Feb 6, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 19,338 | $36.55 | $707K | Form 4 |
| Feb 5, 2026 | John W Childs | Director | Purchase | 294,117 | $17.00 | $5M | Form 4 |
| Feb 5, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 3,832 | $36.07 | $138K | Form 4 |
| Feb 5, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 19,199 | $36.93 | $709K | Form 4 |
| Feb 5, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 38,771 | $37.63 | $1.5M | Form 4 |
| Feb 5, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 17,835 | $38.67 | $690K | Form 4 |
| Feb 5, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 16,563 | $39.80 | $659K | Form 4 |
| Feb 5, 2026 | Vlad Coric | Director | Purchase | 58,823 | $17.00 | $1000K | Form 4 |
| Feb 5, 2026 | Longitude Venture Partners V, L.P. +3 | 10% owner | Purchase | 192,647 | $17.00 | $3.3M | Form 4 |
| Feb 5, 2026 | Longitude Venture Partners V, L.P. +3 | 10% owner | Purchase | 882,353 | $17.00 | $15M | Form 4 |
| Feb 4, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 3,178 | $38.90 | $124K | Form 4 |
| Feb 4, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 10,004 | $34.25 | $343K | Form 4 |
| Feb 4, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 10,676 | $34.74 | $371K | Form 4 |
| Feb 4, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 14,659 | $36.27 | $532K | Form 4 |
| Feb 4, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 53,344 | $37.11 | $2M | Form 4 |
| Feb 4, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 25,908 | $38.09 | $987K | Form 4 |
| Feb 4, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 18,489 | $38.90 | $719K | Form 4 |
| Feb 4, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 1,720 | $34.25 | $58.9K | Form 4 |
| Feb 4, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 1,835 | $34.74 | $63.7K | Form 4 |
| Feb 4, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 2,519 | $36.27 | $91.4K | Form 4 |
| Feb 4, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 9,168 | $37.11 | $340K | Form 4 |
| Feb 4, 2026 | Suvretta Capital Management, Llc +3 | Director | Purchase | 4,453 | $38.09 | $170K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Averill Master Fund, Ltd. | Director | – | $80.4M | Aug 19, 2026 |
| Patrick G Enright | Director | – | $37.6M | Nov 11, 2026 |
| Longitude Venture Partners V, L.P. | 10% owner | $18.3M | – | Feb 5, 2026 |
| John W Childs | Director | $5M | $10.7M | Aug 12, 2026 |
| Suvretta Capital Management, Llc | Director, 10% owner | $10.5M | – | Feb 6, 2026 |
| Reid Alexander Waldman | Chief Executive Officer, Director | – | $7.3M | Aug 17, 2026 |
| Timothy August Durso | Chief Technical Officer | – | $4.7M | Aug 17, 2026 |
| Vlad Coric | Director | $1000K | – | Feb 5, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
MANE short interest
Moderate short interest. 8.1% of MANE shares are sold short: about 1 share in 12. Over the last 12 reports the number of shares short went up 65%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 3.39M MANE shares were sold short, 8.1% of the shares outstanding, down 8.4% from the report before. At the average daily volume of 670,314 shares, buying them all back would take about 5.1 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 3.39M | 8.11% | -8% | 670,314 | 5.1 |
| Oct 15, 2026 | 3.70M | 8.85% | -13% | 982,232 | 3.8 |
| Sep 30, 2026 | 4.24M | 10.16% | +3% | 907,033 | 4.7 |
| Sep 15, 2026 | 4.11M | 9.83% | +2% | 549,395 | 7.5 |
| Aug 31, 2026 | 4.03M | 9.63% | +0% | 608,674 | 6.6 |
| Aug 14, 2026 | 4.01M | 9.60% | -17% | 1.00M | 4.0 |
| Jul 31, 2026 | 4.82M | 12.91% | +22% | 696,545 | 6.9 |
| Jul 15, 2026 | 3.94M | 10.54% | +3% | 560,625 | 7.0 |
| Jun 30, 2026 | 3.81M | 10.20% | +53% | 1.07M | 3.5 |
| Jun 15, 2026 | 2.49M | 6.68% | +5% | 418,000 | 6.0 |
| May 29, 2026 | 2.36M | 6.33% | +15% | 489,899 | 4.8 |
| May 15, 2026 | 2.05M | 5.49% | -0% | 632,150 | 3.2 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Veradermics company events
Veradermics filed 11 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 10, 2026.
- Nov 10, 2026ResultsReleased financial results. Filing
- Nov 9, 2026AnnouncementThe Company announced positive topline results from Part B of its randomized, double-blind, placebo-controlled, registration-directed Phase 2/3 clinical trial (Study ‘302’) evaluating VDPHL01, an investigational, proprietary, extended-release oral minoxidil formulation, in over 500 males with… Filing
- Oct 19, 2026AnnouncementThe Company announced positive topline data from the Phase 3 clinical trial, Study ‘304’ evaluating VDPHL01 in males with mild-to-moderate pattern hair loss. Filing
- Aug 11, 2026ResultsReleased financial results. Filing
- Jul 15, 2026AnnouncementThe Company announced positive topline results from Study ‘207’ evaluating VDPHL01, a proprietary extended-release oral minoxidil formulation, in females with mild-to-moderate pattern hair loss. Filing
- May 12, 2026ResultsReleased financial results. Filing
- May 1, 2026AgreementVeradermics, Incorporated closed its underwritten public offering of 3,843,790 shares of the Company’s common stock, par value $0.00001 per share, at a public offering price of $100.00 per share, pursuant to the Company’s registration statements on Form S-1 (File Nos. 333-295356 and 333-295420). Filing
- Apr 27, 2026ResultsReleased financial results. Filing
- Apr 27, 2026AnnouncementThe Company announced positive topline data from the Phase 2/3 clinical trial, Study ‘302’ evaluating VDPHL01 in males with mild-to-moderate pattern hair loss. Filing
- Mar 30, 2026ResultsReleased financial results. Filing
- Feb 5, 2026RulesChanged its bylaws or articles. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Veradermics financials
Famous investors that hold MANE
4 of the 50 well-known investors we track reported holding MANE in their latest 13F filing. The largest position is Ken Griffin's, worth $248M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 2.05M | $248M | 0.1% | +9% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 941,846 | $114M | 0.9% | +19% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 149,352 | $18.1M | 0.0% | +82% |
| Israel Englander · Millennium Management | Q3 2026 | 4,390 | $532K | 0.0% | -91% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named MANE in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 13, 2026 | Longitude Capital Partners V, LLC | 13D/A | 5.6% |
| Nov 13, 2026 | Longitude Capital Partners V, LLC | 13D/A | 5.6% |
| Oct 13, 2026 | JPMORGAN CHASE & CO. | 13G | 5.6% |
| Oct 13, 2026 | JPMORGAN CHASE & CO. | 13G | 5.6% |
Questions about Veradermics, Inc (MANE) stock
Who owns the most MANE stock?
The largest reported owner of Veradermics, Inc (MANE) is Montanova Capital, LLC, with 11.2% of the company. In total, 164 funds and institutions reported holding MANE at the end of Q2 2026, together about 92% of the shares. See the largest owners.
Are MANE insiders buying or selling?
In the last 12 months, MANE insiders reported 23 open-market purchases worth $34.8M and 16 sales worth $141M. The latest trade was on Nov 11, 2026. See every trade.
What is the short interest in MANE?
As of Oct 30, 2026, 3.39M MANE shares were sold short, 8.1% of the shares outstanding, down 8.4% from the report before. At the average daily volume of 670,314 shares, buying them all back would take about 5.1 trading days (days to cover). See the history.
Which famous investors hold MANE?
4 of the 50 well-known investors we track reported MANE in their latest 13F filing, including Ken Griffin, Lee Ainslie, Jim Simons. The largest position is worth $248M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.